Drug Trial Radar · NCT05421598
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
437
Actual
Start
Jun 30, 2022
Primary completion
Oct 11, 2024
Study completion Mar 20, 2025
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment. The purpose of this study was to assess the efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma. Study details include: * The study duration (per participant) was up to approximately 76 weeks for participants not going into LTS study and will be up to approximately 64 weeks for participants going into LTS study. * The randomized treatment duration was up to approximately 60 weeks. * The scheduled number of visits was 13.
Conditions
- Asthma
Interventions
AmlitelimabDrug
Injection solution Subcutaneous injection
PlaceboDrug
Injection solution Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Severe Asthma Exacerbation Events Over 48 WeeksTime frame: Baseline (Day 1) to Week 48
Locations
113 sites in 14 countries. Site status is shown where the registry gives one.
University of California San Diego Health Site Number : 8400026
La Jolla, California
California Allergy and Asthma Medical Group, Inc. Site Number : 8400002
Los Angeles, California
Allergy Asthma Associates of Santa Clara Valley Site Number : 8400019
San Jose, California
Bensch Clinical Research LLC Site Number : 8400004
Stockton, California
Allianz Research Institute Site Number : 8400023
Westminster, California
Helix Biomedics, LLC Site Number : 8400029
Boynton Beach, Florida
Renaissance Research and Medical Group, Inc Site Number : 8400030
Cape Coral, Florida
Beautiful Minds Clinical Research Center Site Number : 8400027
Cutler Bay, Florida
Reliable Clinical Research, LLC Site Number : 8400020
Hialeah, Florida
Savin Medical Group, LLC Site Number : 8400015
Miami, Florida
Pines Care Research Center LLC Site Number : 8400028
Pembroke Pines, Florida
Treasure Valley Medical Research Site Number : 8400031
Boise, Idaho
The South Bend Clinic, LLC Site Number : 8400033
South Bend, Indiana
University of Kansas Medical Center Site Number : 8400016
Kansas City, Kansas
Johns Hopkins University School of Medicine Site Number : 8400012
Baltimore, Maryland
Headlands Research Detroit Site Number : 8400032
Southfield, Michigan
Henderson Clinical Trials Site Number : 8400037
Henderson, Nevada
Asthma and Allergy Center Site Number : 8400005
Toledo, Ohio
OK Clinical Research, LLC Site Number : 8400001
Edmond, Oklahoma
Allergy, Asthma and Clinical Research Center Site Number : 8400035
Oklahoma City, Oklahoma
TTS Research Site Number : 8400011
Boerne, Texas
Investigational Site Number : 0320004
Buenos Aires, Argentina
Investigational Site Number : 0320003
Ciudad Autonoma Buenos Aires, Argentina
Investigational Site Number : 0320001
CABA, Buenos Aires, Argentina
Investigational Site Number : 0320002
CABA, Buenos Aires, Argentina
Investigational Site Number : 0320008
La Plata, Buenos Aires, Argentina
Investigational Site Number : 0320009
Buenos Aires, Buenos Aires F.D., Argentina
Investigational Site Number : 0320006
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320007
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320005
Rosario, Santa Fe Province, Argentina
CEDOES - Centro de Diagnostico e Pesquisa de Osteoporose do ES Site Number : 0760002
Vitória, Espírito Santo, Brazil
Proar Site Number : 0760004
Salvador, Estado de Bahia, Brazil
Centro Avancado de Oncologia CECAN - Liga Contra o Cancer Site Number : 0760010
Natal, Rio Grande do Norte, Brazil
Instituto Mederi de Pesquisa e Saude Site Number : 0760001
Passo Fundo, Rio Grande do Sul, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre Site Number : 0760007
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Sao Lucas da PUCRS Site Number : 0760006
Porto Alegre, Rio Grande do Sul, Brazil
Hospital das Clinicas de Sao Paulo Site Number : 0760008
São Paulo, São Paulo, Brazil
Clinica de Alergia Martti Antila Site Number : 0760003
Sorocaba, São Paulo, Brazil
Investigational Site Number : 1240003
Québec, Canada
Investigational Site Number : 1240006
Brampton, Ontario, Canada
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.